The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Reasoning
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Cite this ruling
CBP Ruling N316489 (2934993000): The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293499
The tariff classification of Everolimus (CAS-159351-69-6), imported in bulk form, from Switzerland
The tariff classification of Adenosine 5’-Monophosphate (CAS 61-19-8) from China.
The tariff classification of Adenosine 5’-Monophosphate Free Acid (CAS 61-19-8); Cytidine 5’-Monophosphate Free Acid (CAS 63-37-6); Guanosine 5’-Mono-phophate Disodium Salt (CAS 5550-12-9); Uridine 5’-Monophosphate Disodium Salt (CAS 3387-36-8); and Inosine 5’-Monophosphate Disodium Salt (CAS 4691-65-0) from China.
The tariff classification of 4-Chlorothiophene-2-Carboxylic Acid (CAS 59614-95-8) from India.
The tariff classification of Dichlorophenyl Oxathiazole (CAS 67048-88-8) from England.